好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Environmental Pollutants and Cognitive Scores in a Subacute-chronic Mild Traumatic Brain Injury Population
Neuro Trauma and Critical Care
P2 - Poster Session 2 (11:45 AM-12:45 PM)
3-013

To examine the relationship between environmental pollutants and cognition in subacute-chronic mild traumatic brain injury (TBI).

Environmental pollutants like fine particulate matter (PM2.5) and ozone are associated with neurodegenerative diseases. The Montreal Cognitive Assessment (MoCA) is a validated measure to assess cognitive impairment in TBI. CalEnviroScreen 4.0 provides census-tract pollution data that can be used to explore pollutant impact on cognitive health post-TBI, an underexplored topic.

A retrospective (7/2024-8/2025) cohort study of a single-center TBI clinic was performed. Inclusion: ≥18 years old, mild TBI diagnosis per American-Congress-Rehabilitation-Medicine criteria, time from TBI to clinic as ≤12 months, MoCA at first visit, Glasgow Outcome Scale–Extended (GOSE) for functional outcome, complete home address. PM2.5 and ozone scores were extracted from CalEnviroScreen 4.0. MoCA determined cognitive functioning, with <26 defined as cognitive impairment. Performed descriptive statistics, Spearman’s correlation, and multivariable logistic regression to compare normal vs suboptimal MoCA. 

Of 48 patients studied (mean age=46, 76.7% female, 70% non-white), 21 (43.8%) had normal MoCA. Compared to patients with normal MoCA, those with suboptimal MoCA had lower GOSE (5.67 vs 6.43, p=.038), were more likely to have intracranial blood on CT (44.4% vs 9.5%, p=.020), and were from more disadvantaged areas as measured by state area deprivation index (4.70 vs 3.62, p=.040). Patients with suboptimal MoCA came from regions with greater PM2.5 exposure (77.22 vs 60.67, p=.009). This was not seen for ozone exposure. There was a negative correlation between MoCA and PM2.5 (rho=-0.358, p=.013). Accounting for age, sex, race, and high school education, greater PM2.5 exposure (OR=1.058, 95% CI=1.010-1.122, p=.033) and intracranial blood on CT (OR=9.141, 95% CI=1.415-96.754, p=.034) were independently associated with suboptimal (vs normal) MoCA.

Areas with greater environmental pollutants are associated with worse cognitive performance in subacute-chronic mild TBI, making air pollution a potential environmental risk factor in post-TBI cognitive decline.

Authors/Disclosures
Amanda Fang, Undergraduate student
PRESENTER
Miss Fang has nothing to disclose.
Stephania B. Tovar Vargas, MPH Ms. Tovar Vargas has nothing to disclose.
Maral Sakayan, MD (UCI Department of Neurology) Dr. Sakayan has nothing to disclose.
Maria Thereza Paulino Miss Paulino has nothing to disclose.
Alexis Conrad (Neurology Traumatic Brain Injury & Concussion (NTBIC) Program, Department of Neurology, University of California, Irvine, Orange, CA) No disclosure on file
Arunima Kapoor Ms. Kapoor has nothing to disclose.
Danh V. Nguyen, PhD Prof. Nguyen has nothing to disclose.
S. Ahmad Sajjadi, MD, PhD, MRCP, FAAN (University of California, Irvine) Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GUIDEPOINT. Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Research and Therapy. The institution of Dr. Sajjadi has received research support from NIH.
Mark Mapstone, PhD (University of California, Irvine) Dr. Mapstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brain Neurotherapy Bio, Inc. Dr. Mapstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon, Inc. Dr. Mapstone has received intellectual property interests from a discovery or technology relating to health care.
Sigrid Burruss, MD The institution of Dr. Burruss has received research support from BSCC CalVIP.
Areg Grigorian Areg Grigorian has nothing to disclose.
Jeffry Nahmias, MD, MHPE Dr. Nahmias has nothing to disclose.
Michael Lopez, PhD Michael Lopez has nothing to disclose.
Bernadette Boden-Albala, DrPH (University California Irvine) Ms. Boden-Albala has received research support from NIH.
Patrick M. Chen, MD (UC Irvine Medical Center) Dr. Chen has nothing to disclose.